TAMARA MEYERS: Open Payments
NPI 1659558112 · OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$776 in 49 payments from 12 companies in 2025. Trend: 2023 $508 · 2024 $798 · 2025 $776
Food & beverage: $776
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $157 |
| Janssen Biotech, Inc. | 10 | $156 |
| Ardelyx, Inc. | 8 | $137 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $70 |
| Madrigal Pharmaceuticals | 3 | $55 |
| Celltrion USA Inc. | 2 | $39 |
| QOL Medical, LLC | 2 | $37 |
| Organon LLC | 2 | $37 |
| GENZYME CORPORATION | 2 | $30 |
| Lilly USA, LLC | 1 | $22 |
Products named: TREMFYA, IBSRELA, ENTYVIO, CREON, REZDIFFRA, SKYRIZI, RINVOQ, VEGZELMA.
Industry payments across UT — which companies pay providers there.
